HPLC Purification of Synthetic Peptides
High-performance liquid chromatography (HPLC) is the gold standard for purifying synthetic peptides. Reverse-phase HPLC (RP-HPLC) separates peptides based on hydrophobicity, enabling isolation of the target peptide from deletion sequences, truncated products, and other impurities.
Principles of RP-HPLC
Section titled “Principles of RP-HPLC”Stationary Phase
Section titled “Stationary Phase”RP-HPLC uses hydrophobic stationary phases (typically C18 or C8 alkyl chains bonded to silica):
| Phase | Particle Size | Application |
|---|---|---|
| C18 (ODS) | 3–5 µm | Most peptides, standard purification |
| C8 | 3–5 µm | More hydrophobic peptides |
| C4 | 5–10 µm | Very hydrophobic proteins |
| Phenyl-hexyl | 3–5 µm | Aromatic separation |
| Biphenyl | 3–5 µm | Isomer separation |
Mobile Phase
Section titled “Mobile Phase”- Channel A: 0.1% TFA in water (aqueous)
- Channel B: 0.1% TFA in acetonitrile (organic)
- TFA: Ion-pairing agent that improves peak shape and resolution
Separation Mechanism
Section titled “Separation Mechanism”Peptides are retained on the C18 column through hydrophobic interactions. Increasing the acetonitrile concentration (gradient) reduces retention, eluting peptides in order of increasing hydrophobicity.
Analytical vs Preparative HPLC
Section titled “Analytical vs Preparative HPLC”| Parameter | Analytical | Semi-Preparative | Preparative |
|---|---|---|---|
| Column ID | 4.6 mm | 10 mm | 20–50 mm |
| Column length | 150–250 mm | 150–250 mm | 150–300 mm |
| Particle size | 3–5 µm | 5–10 µm | 10–20 µm |
| Flow rate | 1 mL/min | 3–5 mL/min | 20–100 mL/min |
| Injection load | 10–100 µg | 1–10 mg | 10–500 mg |
| Purpose | Purity analysis | Small-scale prep | Large-scale prep |
Method Development
Section titled “Method Development”Initial Gradient Scouting
Section titled “Initial Gradient Scouting”Start with a broad gradient to assess peptide hydrophobicity:
- Column: C18, 4.6 × 150 mm, 5 µm
- Mobile phase: A = 0.1% TFA/H₂O; B = 0.1% TFA/ACN
- Gradient: 5–95% B over 30 minutes
- Flow rate: 1 mL/min
- Detection: UV 220 nm
- Temperature: 25–40°C
Gradient Optimization
Section titled “Gradient Optimization”Based on initial scouting results:
| Elution Time (min) | Recommended Gradient |
|---|---|
| 5–10 | 10–30% B over 30 min |
| 10–15 | 15–40% B over 30 min |
| 15–20 | 20–50% B over 30 min |
| 20–25 | 25–55% B over 30 min |
| 25–30 | 30–60% B over 30 min |
Rule of thumb: Target peptide should elute at 40–60% of the gradient range for optimal resolution.
Mobile Phase Additives
Section titled “Mobile Phase Additives”| Additive | Concentration | Purpose |
|---|---|---|
| TFA | 0.1% | Ion-pairing, improved peak shape |
| Formic acid | 0.1% | MS-compatible alternative to TFA |
| Acetic acid | 1–5% | Mild ion-pairing |
| Ammonium acetate | 10–50 mM | MS-compatible, volatile |
| Guanidine HCl | 6 M | Solubilizes aggregation-prone peptides |
Gradient Optimization Strategies
Section titled “Gradient Optimization Strategies”Shallow Gradients for Difficult Separations
Section titled “Shallow Gradients for Difficult Separations”When deletion sequences co-elute with the target:
- Reduce gradient slope (e.g., 0.5%/min instead of 2%/min)
- Extend gradient over 60–120 minutes
- Optimize column temperature (higher temperature = sharper peaks)
- Consider different stationary phase (C8, phenyl)
Temperature Effects
Section titled “Temperature Effects”| Temperature | Effect |
|---|---|
| 25°C | Standard, broad peaks |
| 35°C | Sharper peaks, reduced retention |
| 50°C | Narrowest peaks, risk of degradation |
| 60°C | Maximum efficiency, monitor stability |
pH Effects
Section titled “pH Effects”| pH | Effect |
|---|---|
| 2.0 (TFA) | Standard, protonates all basic groups |
| 3.0 (Formic acid) | MS-compatible, reduced ion-pairing |
| 4.5 (Acetate) | Closer to physiological, potential resolution improvement |
| 7.0 (Phosphate) | Risk of precipitation, limited use |
Fraction Collection
Section titled “Fraction Collection”Collection Strategies
Section titled “Collection Strategies”- Threshold-based: Collect when UV > 1% of max
- Time-based: Collect in fixed time intervals
- Peak-based: Collect each resolved peak separately
- Composite: Collect leading edge, center, and trailing edge
Pooling Criteria
Section titled “Pooling Criteria”| Fraction | Purity | Action |
|---|---|---|
| Center | >95% | Pool as main product |
| Leading edge | 85–95% | Re-purify or pool separately |
| Trailing edge | 85–95% | Re-purify or pool separately |
| Shoulders | <85% | Discard or re-purify |
Scale-Up Considerations
Section titled “Scale-Up Considerations”| Scale | Column ID | Load | Expected Yield |
|---|---|---|---|
| Analytical | 4.6 mm | 50 µg | 20–30 µg |
| Semi-prep | 10 mm | 5 mg | 2–3 mg |
| Preparative | 20 mm | 50 mg | 20–30 mg |
| Large prep | 50 mm | 500 mg | 200–300 mg |
Common Separation Challenges
Section titled “Common Separation Challenges”Deletion Sequences
Section titled “Deletion Sequences”Peptides missing one or more residues due to incomplete coupling:
- Separation: Achievable if deletion is at a hydrophobic position
- Strategy: Use shallow gradient, optimize pH/temperature
- Challenge: Adjacent residue deletions often co-elute
Truncated Sequences
Section titled “Truncated Sequences”Peptides terminated prematurely:
- Separation: Often easier (significant MW difference)
- Strategy: Standard gradient usually sufficient
- Detection: UV pattern shows multiple peaks
Diastereomers
Section titled “Diastereomers”D-amino acid incorporation (racemization during coupling):
- Separation: Very difficult, may require chiral HPLC
- Prevention: Use HATU, low temperature, short coupling times
Oxidized Products
Section titled “Oxidized Products”Methionine sulfoxide, cysteine disulfide:
- Separation: Often co-elutes with target
- Prevention: Add EDT, TCEP to mobile phase
- Detection: Mass shift +16 Da (Met) or +2 Da (Cys)
Lyophilization After HPLC
Section titled “Lyophilization After HPLC”Procedure
Section titled “Procedure”- Combine purified fractions
- Dilute with water to reduce ACN below 10%
- Flash-freeze in liquid nitrogen
- Lyophilize (48–72 hours)
- Store lyophilized powder at −20°C
Residual TFA Removal
Section titled “Residual TFA Removal”TFA counterions remain after lyophilization:
- Ion exchange: Pass through Dowex 1×8 (acetate form)
- Trapping: Load on C18 cartridge, wash with 0.1% acetic acid
- Dialysis: For large peptides (>5 kDa)
Analytical HPLC for Purity Assessment
Section titled “Analytical HPLC for Purity Assessment”Standard Method
Section titled “Standard Method”| Parameter | Value |
|---|---|
| Column | C18, 4.6 × 150 mm, 5 µm |
| Mobile phase | A: 0.1% TFA/H₂O; B: 0.1% TFA/ACN |
| Gradient | 5–65% B over 30 min |
| Flow rate | 1 mL/min |
| Detection | UV 220 nm (amide), 280 nm (aromatic) |
| Injection | 10–50 µg in water or dilute ACN |
| Temperature | 25°C |
Purity Calculation
Section titled “Purity Calculation”- Area normalization: Purity (%) = (main peak area / total area) × 100
- Target: >95% for research; >98% for clinical use
- Impurity profiling: Identify and quantify all impurities >0.1%
Troubleshooting
Section titled “Troubleshooting”| Problem | Cause | Solution |
|---|---|---|
| Broad peaks | Poor column efficiency | Use newer column, increase temperature |
| Split peaks | Two conformers | Increase temperature, change mobile phase |
| Tail peaks | Silanol interactions | Use high-purity silica column, add triethylamine |
| No retention | Peptide too hydrophilic | Use polar-end-capped column, reduce organic |
| Precipitation | Poor solubility | Increase TFA, use DMSO co-solvent |
| Low recovery | Strong column retention | Use higher organic wash, add 1% acetic acid |
Safety Considerations
Section titled “Safety Considerations”- TFA: Corrosive, volatile — fume hood required
- ACN: Flammable, toxic — avoid inhalation
- High pressure: Use rated columns and fittings
- Lyophilizer: Vacuum hazard — follow standard protocols
References
Section titled “References”- Kratschmar S, et al. “HPLC purification of synthetic peptides.” J Pept Sci 2005;11:605-612.
- Hong J, et al. “Optimization of RP-HPLC for peptide purification.” J Chromatogr A 2012;1232:95-102.
- Mant CT, Hodges RS. “RP-HPLC of peptides.” J Chromatogr A 2005;1089:17-30.
- Albericio F, et al. “Practical aspects of peptide synthesis.” J Pept Res 2004;63:367-382.
- Chen B, et al. “Modern HPLC methods for peptide purification.” Anal Chem 2018;90:6749-6756.